G

Guangxi LiuYao Group Co Ltd
SSE:603368

Watchlist Manager
Guangxi LiuYao Group Co Ltd
SSE:603368
Watchlist
Price: 18.91 CNY -2.32%
Market Cap: 7.5B CNY
Have any thoughts about
Guangxi LiuYao Group Co Ltd?
Write Note

Guangxi LiuYao Group Co Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Guangxi LiuYao Group Co Ltd
Cash & Cash Equivalents Peer Comparison

Comparables:
1099
601607
600998
C
600511
000963

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
G
Guangxi LiuYao Group Co Ltd
SSE:603368
Cash & Cash Equivalents
ÂĄ2.1B
CAGR 3-Years
-2%
CAGR 5-Years
6%
CAGR 10-Years
14%
Sinopharm Group Co Ltd
HKEX:1099
Cash & Cash Equivalents
ÂĄ34.4B
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
11%
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Cash & Cash Equivalents
ÂĄ27.5B
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
9%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Cash & Cash Equivalents
ÂĄ7.9B
CAGR 3-Years
-14%
CAGR 5-Years
-3%
CAGR 10-Years
11%
C
China National Medicines Corp Ltd
SSE:600511
Cash & Cash Equivalents
ÂĄ8.5B
CAGR 3-Years
8%
CAGR 5-Years
13%
CAGR 10-Years
26%
Huadong Medicine Co Ltd
SZSE:000963
Cash & Cash Equivalents
ÂĄ5.4B
CAGR 3-Years
19%
CAGR 5-Years
18%
CAGR 10-Years
16%

See Also

What is Guangxi LiuYao Group Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
2.1B CNY

Based on the financial report for Jun 30, 2024, Guangxi LiuYao Group Co Ltd's Cash & Cash Equivalents amounts to 2.1B CNY.

What is Guangxi LiuYao Group Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
14%

Over the last year, the Cash & Cash Equivalents growth was 12 684%. The average annual Cash & Cash Equivalents growth rates for Guangxi LiuYao Group Co Ltd have been -2% over the past three years , 6% over the past five years , and 14% over the past ten years .

Back to Top